Description: VeraCept is an IUD product. The arms of the product can compress inward with pressure from the uterine walls (unlike a plastic T-shaped device). It contains 175mm2 of copper surface and a flexible nitinol frame measuring 30mm in width x 32mm in height.

Product Details

User: Female

Hormonal: No

Delivery Method: Intrauterine

Duration Type: Long-acting

  • single

Dose: 175 mm2

Active Pharmaceutical Ingredient (API):
  • copper

Inactive material: Nitinol (nickel and titanium composite material) wire

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: ContraMed, LLC

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase II

Active Development: Yes

Status Details:
  • A prospective study of the safety, feasibility and effectiveness of the VeraCept as compared to a concurrently available standard copper IUD (TCu380) ended in 2015. A prospective, multi-center, single-arm, open-label, Phase II clinical study to evaluate the effectiveness, device placement, safety, and tolerability of VeraCept began in 2015. In addition to Phase 2 Clinical Trials in the United States, Veracept is preparing for CE Mark Application in the European Union.

Additional Information


Vertical Tabs